Europe Medical Imaging Market to Reach USD 34.17 Billion by 2030, Driven by AI and Advanced Diagnostic Technologies
Market Estimation, Growth Drivers, and Opportunities
The Europe Medical Imaging Market was valued at USD 21.10 billion in 2023 and is projected to reach USD 34.17 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2030. Medical imaging technologies, including magnetic resonance imaging (MRI), computed tomography (CT), X-ray, and ultrasound, play a critical role in diagnosing diseases, guiding treatment, and monitoring patient outcomes across European healthcare systems.
The market's expansion is supported by Europe's aging population, rising prevalence of cancer and cardiovascular conditions, and growing demand for early and accurate diagnosis. Hospitals and diagnostic facilities increasingly rely on advanced imaging systems to identify diseases, plan treatments, and reduce the need for invasive procedures. Technological progress in image resolution, scanning speed, and digital image processing is further strengthening the role of medical imaging in modern healthcare.
Artificial intelligence (AI) is creating new opportunities by assisting image interpretation, prioritizing urgent cases, and streamlining radiology workflows. Cloud-based image storage, remote diagnostics, and interoperable imaging platforms can improve collaboration between healthcare professionals and support access to specialist services. Manufacturers also have opportunities to develop energy-efficient scanners, reduce examination times, and modernize aging equipment. However, high acquisition and maintenance costs, workforce shortages, and regulatory requirements remain challenges for healthcare providers.
* Get Actionable Market Insights: https://www.maximizemarketresearch.com/request-sample/3359/
US Market Trends and Investment in 2025
The United States continued to influence global medical imaging innovation in 2025 through investments in artificial intelligence, cloud-enabled imaging, and diagnostic workflow technology. In July 2025, GE HealthCare reported that it had reached 100 US Food and Drug Administration authorizations for AI-enabled medical devices, reflecting its continuing investment in research and development. In November 2025, the company announced an agreement to acquire Intelerad for USD 2.3 billion, aiming to strengthen its cloud-based enterprise imaging, image-sharing, and AI workflow capabilities across hospitals and outpatient settings. These developments demonstrate how investment is extending beyond scanners to include software, connected imaging systems, and tools designed to improve diagnostic efficiency. Although these are US market developments rather than direct measures of European demand, they illustrate technologies likely to influence product development and competition among European imaging suppliers.
Market Segmentation: Leading Segments
By product type, Magnetic Resonance Imaging (MRI) was the dominant segment in the European market, supported by its ability to produce detailed images without ionizing radiation. MRI is widely used in neurology, oncology, cardiology, and musculoskeletal diagnostics. Improvements in image reconstruction, scan speed, and patient comfort continue to strengthen its clinical value.
By end user, hospitals represented the dominant segment. Hospitals require a broad range of imaging modalities for emergency care, inpatient diagnosis, cancer assessment, surgical planning, and treatment monitoring. Their high patient volumes and investment in specialized clinical departments sustain demand for advanced imaging equipment and integrated diagnostic systems.
Europe Medical Imaging Market Key players
1. Esaote SpA (Italy)
2. Ziehm Imaging GmbH (Germany)
3. Philips Healthcare (Netherlands)
4. Siemens Healthineers (Germany)
5. Draegerwerk AG & Co. KGaA (Germany)
6. GE Healthcare (UK)
7. Esaote SpA (Italy)
8. SuperSonic Imagine (France)
9. Koninklijke Philips N.V.( Netherlands)
10. Mediso Ltd.(Hungary)
11. MILabs B.V(Netherlands)
12. MR Solutions(, United Kingdom)
Competitive Analysis: Key Companies and Innovation
The market report identifies several established companies in Europe's medical imaging industry. The following five are key players listed in the report; the source does not provide sufficient company-level market-share data to verify a definitive ranking of the five largest by share.
1. Esaote SpA: The Italian medical imaging company specializes in MRI and ultrasound systems. Its focus on dedicated MRI applications and compact imaging solutions offers opportunities in musculoskeletal diagnostics and facilities requiring space-efficient equipment.
2. Ziehm Imaging GmbH: The German company specializes in mobile C-arm imaging systems used in surgical and interventional procedures. Advances in image quality, mobility, and dose management can support demand for image-guided care in operating rooms.
3. Philips Healthcare: In May 2025, Philips announced a collaboration with NVIDIA to develop a foundational AI model for MRI. The initiative aims to improve image quality, accelerate scanning, and enhance diagnostic workflows, potentially increasing the productivity of imaging departments.
4. Siemens Healthineers: The company continues to develop advanced MRI, CT, and molecular imaging technologies. Its emphasis on AI-assisted image reconstruction and faster scanning aligns with hospitals' need to improve diagnostic throughput and maintain image quality.
5. Draegerwerk AG & Co. KGaA: Draegerwerk is included in the report's list of market participants. Its broader hospital technology and patient-monitoring expertise places it within the healthcare equipment ecosystem, although its portfolio is not as focused on diagnostic imaging scanners as those of some competitors.
Regional Analysis: United States, United Kingdom, Germany, France, Japan, and China
United States: The US is an important center for medical imaging innovation, supported by advanced healthcare infrastructure, AI development, and investment in cloud-based diagnostic systems. FDA regulation and reimbursement frameworks influence adoption, while hospitals continue to upgrade imaging equipment to improve diagnostic speed and clinical efficiency.
United Kingdom: The UK benefits from the National Health Service (NHS), established diagnostic networks, and demand for timely access to scans. NHS digital transformation initiatives and evaluation of AI-assisted diagnostic tools create opportunities for technologies that can help radiologists manage workloads and prioritize urgent cases.
Germany: Germany held the largest country-level share of the European medical imaging market in 2023, according to the report. Its advanced hospital infrastructure, strong medical technology industry, and presence of Siemens Healthineers support demand for MRI, CT, and other imaging systems. The Hospital Future Act (Krankenhauszukunftsgesetz) has also supported hospital digitalization and modernization, strengthening the environment for technology upgrades.
France: France's healthcare infrastructure, cancer-diagnosis requirements, and investment in advanced clinical technologies support medical imaging demand. Government-backed healthcare modernization and research initiatives create opportunities for AI-assisted diagnosis, advanced scanners, and improved access to specialized imaging.
Japan: Japan's aging population and established healthcare technology sector support demand for imaging systems used to diagnose cancer, cardiovascular conditions, and neurological disorders. Healthcare providers are also interested in technologies that improve diagnostic efficiency and address staffing pressures.
China: China's large patient population, expanding hospital infrastructure, and investments in healthcare modernization create opportunities for medical imaging suppliers. Domestic equipment development and demand for advanced diagnostic services are supporting the adoption of MRI, CT, and digital imaging technologies. However, China and Japan are outside the European market covered by this report, and no European-market country shares are assigned to them here.
Related Reports:
Biosimulation Market https://www.maximizemarketresearch.com/market-report/global-biosimulation-market/3396/
Global Flash Chromatography Market https://www.maximizemarketresearch.com/market-report/global-flash-chromatography-market/20819/
Global Cardiology Information System Market https://www.maximizemarketresearch.com/market-report/global-cardiology-information-system-market/31974/
Conclusion
The Europe Medical Imaging Market is positioned for continued growth as aging populations, chronic diseases, and demand for early diagnosis increase the need for advanced diagnostic equipment. MRI and hospital-based imaging remain central to market demand, while AI-assisted reconstruction, cloud-based image management, and faster scanning technologies are creating new opportunities. In my view, the strongest growth potential lies in helping healthcare providers improve diagnostic capacity while controlling operating costs. Companies that combine reliable imaging performance with efficient workflows, AI integration, and patient-centered design will be better positioned to benefit from Europe's ongoing healthcare modernization.
About Maximize Market Research
Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting firm known for delivering accurate, actionable, and data-driven insights. Our expertise spans diverse industries — including medical devices, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. We provide services such as market-validated forecasts, competitive intelligence, strategic consulting, and industry impact analysis, helping businesses navigate market complexities and achieve sustainable growth.
Contact Maximize Market Research
MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Naval IT Park Phase 3,
Pune-Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India.
📞 +91 9607365656
📧 [email protected]